<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00430118</url>
  </required_header>
  <id_info>
    <org_study_id>CDR0000528029</org_study_id>
    <secondary_id>ALL-BFM-2000</secondary_id>
    <secondary_id>EU-20682</secondary_id>
    <nct_id>NCT00430118</nct_id>
  </id_info>
  <brief_title>Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia</brief_title>
  <official_title>ALL-BFM 2000 Multi-Center Study for the Treatment of Children and Adolescents With Acute Lymphoblastic Leukemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Schleswig-Holstein</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Schleswig-Holstein</source>
  <brief_summary>
    <textblock>
      RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of cancer
      cells, either by killing the cells or by stopping them from dividing. Giving more than one
      drug (combination chemotherapy) may kill more cancer cells. It is not yet known which
      combination chemotherapy regimen is more effective in treating young patients with acute
      lymphoblastic leukemia.

      PURPOSE: Thisphase III trial is studying several different combination chemotherapy regimens
      to compare how well they work in treating young patients with acute lymphoblastic leukemia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

        -  Compare the relative efficacy of induction therapy comprising dexamethasone or
           prednisone, in terms of a higher rate of event-free survival (EFS) and overall survival
           and a reduced rate of relapse, in pediatric patients with intermediate-risk or high-risk
           acute lymphoblastic leukemia (ALL).

        -  Compare the relative safety of a reduced-intensity reintensification regimen comprising
           dexamethasone, vincristine, cyclophosphamide, and anthracyclines vs a standard treatment
           regimen in pediatric patients with standard-risk ALL identified by fast clearance of
           leukemic cells.

        -  Compare the efficacy of a second delayed reintensification regimen vs standard
           reintensification therapy, in terms of improved EFS, in pediatric patients with
           intermediate-risk ALL.

        -  Compare the efficacy of extended reintensification therapy (triple reinduction) vs
           standard reintensification therapy (intensive pulses and one reintensification) in
           pediatric patients with high-risk ALL.

      OUTLINE: This is a randomized, multicenter study.

        -  Prednisone prephase therapy: Patients receive oral prednisone on days 1-7 and one dose
           of methotrexate (MTX) intrathecally (IT) on day 1.

        -  Induction/consolidation therapy, protocol I: Patients are randomized to 1 of 2 treatment
           arms.

             -  Arm I (closed to accrual as of 6/30/2006): Patients receive prednisone (PRED) on
                days 8-28.

             -  Arm II (closed to accrual as of 6/30/2006): Patients receive dexamethasone (DEXA)
                on days 8-28.

      Patients in both arms also receive vincristine (VCR) and daunorubicin hydrochloride (DNR)
      once weekly in weeks 2-5; asparaginase (ASP) on days 12-33; cyclophosphamide (CPM) on days 36
      and 64; cytarabine (ARA-C) in weeks 6-9; mercaptopurine (MP) on days 36-63; and MTX IT on
      days 1, 12, 33, 45, and 59.*

      NOTE: *Patients with CNS disease also receive MTX IT on days 18 and 27.

      After completion of induction/consolidation therapy, patients are stratified according to
      risk group based on disease response (standard-risk [SR] group [negative minimal residual
      disease (MRD) on day 33 and before protocol M, day 78] vs high-risk [HR] group [MRD ≥ 10^-³
      on day 78] vs intermediate-risk [IR] group [all nonSR/nonHR]).* Patients with SR and IR
      disease proceed to extracompartment therapy. Patients with HR disease proceed to
      reintensification therapy.

      NOTE: *Patients meeting any of the following criteria are placed in the HR group regardless
      of MRD response: Philadelphia chromosome-positive disease (BCR/ABL or t[9;22]; translocations
      [t4;11][q11;q23] or MLL/AF4); &quot;prednisone-poor-response&quot; (≥ 1,000 blasts/mm³ in the
      peripheral blood on day 8 after prednisone prephase therapy); or no response to study
      induction therapy (M2/3 at day 33).

        -  Extracompartment therapy, protocol M: Patients receive MP on days 1-56 and MTX on days
           8, 22, 36, and 50.

      After completion of extracompartment therapy, SR and IR patients proceed to reintensification
      therapy. SR patients are randomized to arms I or II. IR patients are randomized to arms I or
      III. HR patients who have completed induction/consolidation therapy are randomized to arms IV
      or V.

        -  Reintensification therapy:

             -  Arm I (standard reinduction therapy, protocol II [closed to accrual as of
                6/30/2006]): SR and IR patients receive DEXA on days 1-22; VCR and doxorubicin
                hydrochloride (DOX) in weeks 2-5; ASP on days 8, 11, 15, and 18; CPM on day 36;
                ARA-C and thioguanine (TG) on days 36-49; and MTX IT on days 38 and 45.* Patients
                then proceed to maintenance therapy.

      NOTE: *Patients with CNS disease also receive MTX IT on days 1 and 18.

        -  Arm II (reduced-intensity reinduction therapy, protocol III [closed to accrual as of
           6/30/2006]): SR patients receive DEXA on days 1-15; VCR and DOX on days 1 and 8; ASP on
           days 1, 4, 8, and 11; CPM on day 15; ARA-C and TG on days 15-28; and MTX IT on days 17
           and 24.* Patients then proceed to maintenance therapy.

      NOTE: *Patients with CNS disease also receive MTX on day 1.

        -  Arm III (reduced-intensity reinduction/second delayed reinduction therapy [double
           reintensification therapy] [closed to accrual as of 6/30/2006]): IR patients receive
           reduced-intensity reintensification therapy as in arm II. After a 10-week interim
           maintenance phase, treatment repeats once for a second delayed course of
           reintensification therapy. Patients then proceed to maintenance therapy.

        -  Arm IV (standard reintensification therapy [closed to accrual as of 6/30/2006]): HR
           patients receive two sequences of the following HR therapy elements (i.e., in this
           order: 1, 2, 3, 1, 2, 3) following reintensification therapy as in arm I. Patients then
           proceed to maintenance therapy.

             -  Element HR-1: Patients receive DEXA on days 1-5; VCR on days 1 and 6; ARA-C twice
                on day 5; MTX and CPM every 12 hours on days 2-4 (5 doses); ASP on days 6 and 11;
                and MTX/ARA-C/PRED IT on day 1.

             -  Element HR-2: Patients receive DEXA on days 1-5; vindesine on days 1 and 6; DNR on
                day 5; MTX and ifosfamide every 12 hours on days 2-4 (5 doses); ASP on days 6 and
                11; and MTX/ARA-C/PRED IT on day 1.* NOTE: *HR patients with CNS disease also
                receive IT therapy on day 5.

             -  Element HR-3: Patients receive DEXA on days 1-5; ARA-C every 12 hours on days 1-2
                (4 doses); etoposide five times daily on days 3-5; ASP on days 6 and 11; and
                MTX/ARA-C/PRED IT on day 1.

        -  Arm V (extended reintensification therapy [triple protocol III] [closed to accrual as of
           6/30/2006]): HR patients receive HR therapy elements 3, 2, and 1 as in arm IV following
           reintensification therapy as in arm II repeated the therapy element twice with 4-week
           interim maintenance phases in between. Patients then proceed to maintenance therapy.

             -  Interim maintenance/maintenance therapy: Patients receive MTX once weekly and MP
                daily until week 104.

             -  Radiotherapy: HR patients or patients with T-cell acute lymphoblastic leukemia or
                CNS disease undergo CNS radiotherapy.

      PROJECTED ACCRUAL: A total of 2,000 patients will be accrued for this study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2000</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of dexamethasone vs prednisone during the induction phase</measure>
    <time_frame>End of Trial</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Event-free survival (EFS) and overall survival after initial remission in intermediate-risk and high-risk patients</measure>
    <time_frame>End of Trial</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety and efficacy of treatment reduction during reintensification in standard-risk patients</measure>
    <time_frame>End of Trial</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>EFS after second delayed reintensification in intermediate-risk patients</measure>
    <time_frame>End of Trial</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Outcome after extended reintensification therapy in high-risk patients</measure>
    <time_frame>End of Trial</time_frame>
  </primary_outcome>
  <number_of_arms>10</number_of_arms>
  <enrollment type="Actual">4559</enrollment>
  <condition>Leukemia</condition>
  <arm_group>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot III</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot III</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot II</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot II</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Induction Prot I/Dexa - reinduction 2x Prot III</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Induction Prot I/Pred - reinduction 2x Prot III</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Induction Prot I/Dexa - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Induction Prot I/Pred - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Induction Prot I/Dexa - reinduction 6 HR courses + Prot II</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Induction Prot I/Pred - reinduction 6 HR courses + Prot II</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>asparaginase</intervention_name>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 6 HR courses + Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 6 HR courses + Prot II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>cyclophosphamide</intervention_name>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 6 HR courses + Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 6 HR courses + Prot II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>cytarabine</intervention_name>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 6 HR courses + Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 6 HR courses + Prot II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>daunorubicin hydrochloride</intervention_name>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 6 HR courses + Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 6 HR courses + Prot II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexamethasone</intervention_name>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 6 HR courses + Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 6 HR courses + Prot II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>doxorubicin hydrochloride</intervention_name>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 6 HR courses + Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 6 HR courses + Prot II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>etoposide</intervention_name>
    <arm_group_label>Induction Prot I/Dexa - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 6 HR courses + Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 6 HR courses + Prot II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ifosfamide</intervention_name>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 6 HR courses + Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 6 HR courses + Prot II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>mercaptopurine</intervention_name>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 6 HR courses + Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 6 HR courses + Prot II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>methotrexate</intervention_name>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 6 HR courses + Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 6 HR courses + Prot II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>prednisone</intervention_name>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 6 HR courses + Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 6 HR courses + Prot II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>thioguanine</intervention_name>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 6 HR courses + Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 6 HR courses + Prot II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>vincristine sulfate</intervention_name>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 6 HR courses + Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 6 HR courses + Prot II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>vindesine</intervention_name>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 6 HR courses + Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 6 HR courses + Prot II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>radiation therapy</intervention_name>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 2x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 3 HR courses + 3x Prot III</arm_group_label>
    <arm_group_label>Induction Prot I/Dexa - reinduction 6 HR courses + Prot II</arm_group_label>
    <arm_group_label>Induction Prot I/Pred - reinduction 6 HR courses + Prot II</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:

          -  Histologically confirmed acute lymphoblastic leukemia (ALL)

          -  No secondary ALL

        PATIENT CHARACTERISTICS:

          -  No prior disease that would preclude treatment with chemotherapy

        PRIOR CONCURRENT THERAPY:

          -  More than 4 weeks since prior chemotherapy

          -  More than 4 weeks since prior steroids
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Schrappe, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Schleswig-Holstein</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Krankenhaus Dornbirn</name>
      <address>
        <city>Dornbirn</city>
        <zip>A-6850</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Landeskrankenhaus Feldkirch</name>
      <address>
        <city>Feldkirch-Tisis</city>
        <zip>A-6807</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaet Kinderklinik</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Innsbruck Universitaetsklinik</name>
      <address>
        <city>Innsbruck</city>
        <zip>A-6020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Landeskrankenhaus Klagenfurt</name>
      <address>
        <city>Klagenfurt</city>
        <zip>9026</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LKH Leoben</name>
      <address>
        <city>Leoben</city>
        <zip>A-8700</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A. oe. Krankenhaus der Barmherzigen Schwestern Kinderabteilung</name>
      <address>
        <city>Linz</city>
        <zip>4010</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Landes-Kinderkrankenhaus</name>
      <address>
        <city>Linz</city>
        <zip>A-4020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Johanns-Spital</name>
      <address>
        <city>Salzburg</city>
        <zip>A-5020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Anna Children's Hospital</name>
      <address>
        <city>Vienna</city>
        <zip>A-1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinderklinik - Universitaetsklinikum Aachen</name>
      <address>
        <city>Aachen</city>
        <zip>D-52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Augsburg</name>
      <address>
        <city>Augsburg</city>
        <zip>DOH-86156</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Caritas-Krankenhaus Bad Mergentheim</name>
      <address>
        <city>Bad Mergentheim</city>
        <zip>D-97980</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Bayreuth</name>
      <address>
        <city>Bayreuth</city>
        <zip>D-95445</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helios Klinikum Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13125</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charite University Hospital - Campus Virchow Klinikum</name>
      <address>
        <city>Berlin</city>
        <zip>D-13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinderklinik der Universitaet Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>D-53113</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Staedtisches Klinikum - Howedestrase</name>
      <address>
        <city>Braunschweig</city>
        <zip>38118</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Chemnitz gGmbH</name>
      <address>
        <city>Chemnitz</city>
        <zip>D-09116</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Coburg</name>
      <address>
        <city>Coburg</city>
        <zip>96450</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kliniken der Stadt Koeln gGmbH - Kinderkrankenhaus Riehl</name>
      <address>
        <city>Cologne</city>
        <zip>D-50735</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital</name>
      <address>
        <city>Cologne</city>
        <zip>D-50924</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carl - Thiem - Klinkum Cottbus</name>
      <address>
        <city>Cottbus</city>
        <zip>D-03048</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vestische Kinderklinik Universitaetsklinik Witten/Herdecke</name>
      <address>
        <city>Datteln</city>
        <zip>45711</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Lippe - Detmold</name>
      <address>
        <city>Detmold</city>
        <zip>D-32756</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Dortmund</name>
      <address>
        <city>Dortmund</city>
        <zip>D-44137</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Carl Gustav Carus</name>
      <address>
        <city>Dresden</city>
        <zip>D-01307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Duisburg</name>
      <address>
        <city>Duisburg</city>
        <zip>D-47055</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helios Klinikum Erfurt</name>
      <address>
        <city>Erfurt</city>
        <zip>99089</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaets - Kinderklinik</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Essen</name>
      <address>
        <city>Essen</city>
        <zip>D-45147</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum der J.W. Goethe Universitaet</name>
      <address>
        <city>Frankfurt</city>
        <zip>D-60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetskinderklinik - Universitaetsklinikum Freiburg</name>
      <address>
        <city>Freiburg</city>
        <zip>D-79106</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinderklinik</name>
      <address>
        <city>Giessen</city>
        <zip>D-35385</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Goettingen</name>
      <address>
        <city>Goettingen</city>
        <zip>D-37075</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Halle</name>
      <address>
        <city>Halle</city>
        <zip>D-06097</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>D-30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaets-Kinderklinik Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>D-69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen</name>
      <address>
        <city>Heilbronn</city>
        <zip>D-74064</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftskrankenhaus</name>
      <address>
        <city>Herdecke</city>
        <zip>58313</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum des Saarlandes</name>
      <address>
        <city>Homburg</city>
        <zip>66421</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaets - Kinderklinik</name>
      <address>
        <city>Jena</city>
        <zip>D-07745</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Staedtisches Klinikum Karlsruhe gGmbH</name>
      <address>
        <city>Karlsruhe</city>
        <zip>76133</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Kassel</name>
      <address>
        <city>Kassel</city>
        <zip>D-34125</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Schleswig-Holstein - Kiel Campus</name>
      <address>
        <city>Kiel</city>
        <zip>D-24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Kemperhof Koblenz</name>
      <address>
        <city>Koblenz</city>
        <zip>D-56065</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Annastift Krankenhaus</name>
      <address>
        <city>Ludwigshafen</city>
        <zip>67065</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaets - Kinderklinik - Luebeck</name>
      <address>
        <city>Luebeck</city>
        <zip>D-23538</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum der MA</name>
      <address>
        <city>Magdeburg</city>
        <zip>39120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Staedtisches Klinik - Kinderklinik</name>
      <address>
        <city>Mannheim</city>
        <zip>D-68167</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Giessen und Marburg GmbH - Marburg</name>
      <address>
        <city>Marburg</city>
        <zip>D-35043</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Minden</name>
      <address>
        <city>Minden</city>
        <zip>D-32423</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik und Poliklinik fuer Kinder und Jugendmedizin - Universitaetsklinikum Muenster</name>
      <address>
        <city>Muenster</city>
        <zip>D-48149</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Muenchen Schwabing</name>
      <address>
        <city>Munich</city>
        <zip>80804</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinderklinik Kohlhof</name>
      <address>
        <city>Neunkirchen</city>
        <zip>D-66539</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cnopf'sche Kinderklinik</name>
      <address>
        <city>Nuremberg</city>
        <zip>90419</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Oldenburg</name>
      <address>
        <city>Oldenburg</city>
        <zip>26133</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinderklinik - Universitaetsklinikum Rostock</name>
      <address>
        <city>Rostock</city>
        <zip>D-18057</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saarbrucker Winterbergkliniken</name>
      <address>
        <city>Saarbrucken</city>
        <zip>66119</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Schwerin</name>
      <address>
        <city>Schwerin</city>
        <zip>D-19049</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinderklink Siegen Deutsches Rotes Kreuz</name>
      <address>
        <city>Siegen</city>
        <zip>D-57072</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johanniter-Kinderklinik</name>
      <address>
        <city>St. Augustin</city>
        <zip>53757</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Olgahospital</name>
      <address>
        <city>Stuttgart</city>
        <zip>D-70176</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenanstalt Mutterhaus der Borromaerinnen</name>
      <address>
        <city>Trier</city>
        <zip>D-54290</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Tuebingen</name>
      <address>
        <city>Tuebingen</city>
        <zip>D-72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm</name>
      <address>
        <city>Ulm</city>
        <zip>D-89075</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Marienhospital - Vechta</name>
      <address>
        <city>Vechta</city>
        <zip>D-49377</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Reinhard-Nieter-Krankenhaus</name>
      <address>
        <city>Wilhelmshaven</city>
        <zip>D-26389</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum der Stadt Wolfsburg</name>
      <address>
        <city>Wolfsburg</city>
        <zip>D-38440</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaets - Kinderklinik Wuerzburg</name>
      <address>
        <city>Wuerzburg</city>
        <zip>D-97080</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kantonsspital Aarau</name>
      <address>
        <city>Aarau</city>
        <zip>CH-5001</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaets-Kinderspital beider Basel</name>
      <address>
        <city>Basel</city>
        <zip>CH-4005</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale &quot;la Carita&quot;, Locarno</name>
      <address>
        <city>Locarno</city>
        <zip>6600</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinderspital Luzern</name>
      <address>
        <city>Lucerne 16</city>
        <zip>CH-6000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ostschweizer Kinderspital</name>
      <address>
        <city>St. Gallen</city>
        <zip>CH-9006</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Children's Hospital</name>
      <address>
        <city>Zurich</city>
        <zip>CH-8032</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Attarbaschi A, Mann G, Panzer-Grümayer R, Röttgers S, Steiner M, König M, Csinady E, Dworzak MN, Seidel M, Janousek D, Möricke A, Reichelt C, Harbott J, Schrappe M, Gadner H, Haas OA. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials. J Clin Oncol. 2008 Jun 20;26(18):3046-50. doi: 10.1200/JCO.2008.16.1117.</citation>
    <PMID>18565891</PMID>
  </reference>
  <results_reference>
    <citation>Schrappe M, Valsecchi MG, Bartram CR, Schrauder A, Panzer-Grümayer R, Möricke A, Parasole R, Zimmermann M, Dworzak M, Buldini B, Reiter A, Basso G, Klingebiel T, Messina C, Ratei R, Cazzaniga G, Koehler R, Locatelli F, Schäfer BW, Aricò M, Welte K, van Dongen JJ, Gadner H, Biondi A, Conter V. Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. Blood. 2011 Aug 25;118(8):2077-84. doi: 10.1182/blood-2011-03-338707. Epub 2011 Jun 30.</citation>
    <PMID>21719599</PMID>
  </results_reference>
  <results_reference>
    <citation>Conter V, Bartram CR, Valsecchi MG, Schrauder A, Panzer-Grümayer R, Möricke A, Aricò M, Zimmermann M, Mann G, De Rossi G, Stanulla M, Locatelli F, Basso G, Niggli F, Barisone E, Henze G, Ludwig WD, Haas OA, Cazzaniga G, Koehler R, Silvestri D, Bradtke J, Parasole R, Beier R, van Dongen JJ, Biondi A, Schrappe M. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood. 2010 Apr 22;115(16):3206-14. doi: 10.1182/blood-2009-10-248146. Epub 2010 Feb 12.</citation>
    <PMID>20154213</PMID>
  </results_reference>
  <results_reference>
    <citation>Kox C, Zimmermann M, Stanulla M, Leible S, Schrappe M, Ludwig WD, Koehler R, Tolle G, Bandapalli OR, Breit S, Muckenthaler MU, Kulozik AE. The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function. Leukemia. 2010 Dec;24(12):2005-13. doi: 10.1038/leu.2010.203. Epub 2010 Oct 14.</citation>
    <PMID>20944675</PMID>
  </results_reference>
  <results_reference>
    <citation>Schrey D, Borghorst S, Lanvers-Kaminsky C, Hempel G, Gerss J, Möricke A, Schrappe M, Boos J. Therapeutic drug monitoring of asparaginase in the ALL-BFM 2000 protocol between 2000 and 2007. Pediatr Blood Cancer. 2010 Jul 1;54(7):952-8. doi: 10.1002/pbc.22417.</citation>
    <PMID>20108339</PMID>
  </results_reference>
  <results_reference>
    <citation>Dworzak MN, Schumich A, Printz D, Pötschger U, Husak Z, Attarbaschi A, Basso G, Gaipa G, Ratei R, Mann G, Gadner H. CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy. Blood. 2008 Nov 15;112(10):3982-8. doi: 10.1182/blood-2008-06-164129. Epub 2008 Sep 9.</citation>
    <PMID>18780832</PMID>
  </results_reference>
  <results_reference>
    <citation>Flohr T, Schrauder A, Cazzaniga G, Panzer-Grümayer R, van der Velden V, Fischer S, Stanulla M, Basso G, Niggli FK, Schäfer BW, Sutton R, Koehler R, Zimmermann M, Valsecchi MG, Gadner H, Masera G, Schrappe M, van Dongen JJ, Biondi A, Bartram CR; International BFM Study Group (I-BFM-SG). Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia. 2008 Apr;22(4):771-82. doi: 10.1038/leu.2008.5. Epub 2008 Jan 31.</citation>
    <PMID>18239620</PMID>
  </results_reference>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 30, 2007</study_first_submitted>
  <study_first_submitted_qc>January 30, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2007</study_first_posted>
  <last_update_submitted>May 28, 2013</last_update_submitted>
  <last_update_submitted_qc>May 28, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 29, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Schleswig-Holstein</investigator_affiliation>
    <investigator_full_name>Martin Schrappe</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <keyword>T-cell childhood acute lymphoblastic leukemia</keyword>
  <keyword>recurrent childhood acute lymphoblastic leukemia</keyword>
  <keyword>untreated childhood acute lymphoblastic leukemia</keyword>
  <keyword>B-cell childhood acute lymphoblastic leukemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leukemia</mesh_term>
    <mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
    <mesh_term>Leukemia, Lymphoid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Prednisone</mesh_term>
    <mesh_term>Liposomal doxorubicin</mesh_term>
    <mesh_term>Cyclophosphamide</mesh_term>
    <mesh_term>Doxorubicin</mesh_term>
    <mesh_term>Methotrexate</mesh_term>
    <mesh_term>Etoposide</mesh_term>
    <mesh_term>Cytarabine</mesh_term>
    <mesh_term>Vincristine</mesh_term>
    <mesh_term>Ifosfamide</mesh_term>
    <mesh_term>Daunorubicin</mesh_term>
    <mesh_term>Asparaginase</mesh_term>
    <mesh_term>6-Mercaptopurine</mesh_term>
    <mesh_term>Thioguanine</mesh_term>
    <mesh_term>Vindesine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

